Oral nalbuphine - PhytoHealth

Drug Profile

Oral nalbuphine - PhytoHealth

Alternative Names: PHN-131

Latest Information Update: 26 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PhytoHealth
  • Class Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Pain

Most Recent Events

  • 19 Jul 2016 Preregistration for Pain in Taiwan (PO) (Phytohealth Company Introduction, July 2016)
  • 01 Apr 2013 Phase-II/III clinical trials in Pain in Taiwan (PO)
  • 16 Oct 2008 Phase-I clinical trials in Pain in Taiwan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top